The increasing interest in effective weight management has spurred considerable exploration into cutting-edge treatments. Recently , Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like here peptide-1 (GLP-1) receptor stimulator, has demonstrated encouraging results in medical trials, indicating poten